Relative efficacy of tafamidis, acoramidis, patisiran and vutrisiran in patients with transthyretin cardiac amyloidosis: a network meta-analysis.

Attruby (acoramidis) - BridgeBio

Onpattro (patisiran) - Alnylam, Sanofi

Vyndaqel (tafamidis meglumine) - Pfizer

Amvuttra (vutrisiran) - Alnylam

http://www.ncbi.nlm.nih.gov/pubmed/41282536

Alberto Aimo; Giuseppe Vergaro; Michele Emdin; Valentina Lorenzoni; Vincenzo Castiglione

Nov 24, 2025